PEPTONIC medical AB (publ) (FRA:28L)
0.0002
0.00 (0.00%)
At close: Nov 28, 2025
PEPTONIC medical AB Company Description
PEPTONIC medical AB (publ), a pharmaceutical company, researches, develops, and sells medical treatments and lifestyle products in the field of women's health.
It offers VagiVital, a hormone-free treatment for symptoms related to vaginal atrophy, such as pain during intercourse, burning, itching, and dryness, as well as moisturizing and an oil-based intimate wash.
The company also provides lifestyle consumer products under the Lunette brand. PEPTONIC medical AB (publ) was incorporated in 2009 and is headquartered in Bromma, Sweden.
PEPTONIC medical AB (publ)
| Country | Sweden |
| Founded | 2009 |
| Industry | Pharmaceutical Preparations |
| Employees | 27 |
| CEO | Anna Linton |
Contact Details
Address: Gustavslundsvägen 143 Bromma, 167 51 Sweden | |
| Phone | 46 8 53 02 01 10 |
| Website | peptonicmedical.se |
Stock Details
| Ticker Symbol | 28L |
| Exchange | Frankfurt Stock Exchange |
| Share Class | Class A Shares |
| Fiscal Year | January - December |
| Reporting Currency | SEK |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Anna Linton | Chief Executive Officer |
| Jenni Bjornulfson | Chief Financial Officer |